MUR
44
-3
CINF
53
3
TGT
45
-4
AZO
50
-5
STI
45
26
AIZ
82
2
VMC
53
-4
T
48
3
COF
62
3
JBHT
56
-3
FMC
23
-3
OMC
50
-16
AON
54
2
AAP
35
-9
EXR
57
2
NWS
75
-4
GT
56
-3
MSFT
48
-9
ECL
55
-2
EXC
54
3
MUR
44
-3
CINF
53
3
TGT
45
-4
AZO
50
-5
STI
45
26
AIZ
82
2
VMC
53
-4
T
48
3
COF
62
3
JBHT
56
-3
FMC
23
-3
OMC
50
-16
AON
54
2
AAP
35
-9
EXR
57
2
NWS
75
-4
GT
56
-3
MSFT
48
-9
ECL
55
-2
EXC
54
3
Financhill
Back

Reliance Global Group Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
9

RELI
Reliance Global Group

Last Price:
1.45
Seasonality Move:
2428.27%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
9
Reliance Global Group (RELI) is a Sell

Is Reliance Global Group a Buy, Sell or Hold?

  • The current Reliance Global Group [RELI] share price is $1.45. The Score for RELI is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RELI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RELI Stock Price Chart

What is Reliance Global Group's stock price today?

  • The Reliance Global Group share price today is $1.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RELI is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RELI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 21.29 Sell
Chaikin Money Flow: -32476 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.9 - 2.42) Sell
Bollinger Bands (100): (2.11 - 3.59) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RELI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.85 Sell
20-day SMA: 2.14 Sell
50-day SMA: 2.31 Sell
200-day SMA: 4.45 Sell
8-day EMA: 1.8 Sell
20-day EMA: 2.03 Sell
50-day EMA: 2.35 Sell
200-day EMA: 11.25 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Reliance Global Group Earnings Growth & RELI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Reliance Global Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):